Versant Ventures
Versant Ventures is a venture capital firm focused on creating and financing biotechnology companies. The firm operates in-house Discovery Engines—multidisciplinary scientific teams with laboratory facilities—that partner with academic founders to launch novel biotech companies. Versant reports global operations, multiple offices and discovery sites, and active participation in company formation, financings, collaborations and exits.
Industries
financial-services
health-care
venture-capital-b37d
Nr. of Employees
small (1-50)
Versant Ventures
Ridgeline, Hochbergerstrasse 60C, Basel, Switzerland
Portfolio
Closed $85M Series B (Jan 9, 2019); Versant announced a successful IPO for Black Diamond (Jan 29, 2020).
#Biotechnology / Targeted oncology
Closed $85M Series B (Jan 9, 2019); Versant announced a successful IPO for Black Diamond (Jan 29, 2020).
#Biotechnology / Targeted oncology